Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

Gene Therapy ◽

10.1038/gt.2011.1 ◽

2011 ◽

Vol 18 (6) ◽

pp. 584-593 ◽

Author(s):

J C Steele ◽

A Rao ◽

J R Marsden ◽

C J Armstrong ◽

S Berhane ◽

...

Keyword(s):

Dendritic Cell ◽

Phase I ◽

Metastatic Melanoma ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Download Full-text

A phase I/II study of a multivalent dendritic cell vaccine in patients with metastatic melanoma

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.2542 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 2542-2542

Author(s):

I. Gorin ◽

M. Prince ◽

J.-J. Grob ◽

M.-T. Leccia ◽

T. Lesimple ◽

...

Keyword(s):

Dendritic Cell ◽

Phase I ◽

Metastatic Melanoma ◽

Dendritic Cell Vaccine ◽

Download Full-text

Faculty Opinions recommendation of Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1001806.12205 ◽

2001 ◽

Author(s):

Pedro Romero

Keyword(s):

Dendritic Cell ◽

Metastatic Melanoma ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Clinical Responses

Download Full-text

Abstract LB-157: IL-12p70 producing dendritic cell vaccine elicits Tc1 polarized T cells and extends time to progression in metastatic melanoma.

10.1158/1538-7445.am2013-lb-157 ◽

2013 ◽

Author(s):

Beatriz M. Carreno ◽

Michelle Becker-Hapak ◽

Alexander Huang ◽

Megan Chan ◽

Amer Alyasiry ◽

...

Keyword(s):

T Cells ◽

Dendritic Cell ◽

Metastatic Melanoma ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Time To Progression

Download Full-text

Abstract CT016: A first in man phase I/II adjuvant dendritic cell vaccine study in high-risk prostate cancer patients following radical surgery reduce the incidence of biochemical relapse

10.1158/1538-7445.am2018-ct016 ◽

2018 ◽

Author(s):

Anne Merete Tryggestad ◽

Iris Bigalke ◽

Karol Axcrona ◽

Bjørn Brennhovd ◽

T Kirsti Hønnåshagen ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Biochemical Relapse ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Results from a first in man Phase I/II adjuvant Dendritic Cell Vaccine study in high risk prostate cancer patients following radical surgery

Cytotherapy ◽

10.1016/j.jcyt.2017.02.025 ◽

2017 ◽

Vol 19 (5) ◽

pp. S15 ◽

Author(s):

A.A. Tryggestad ◽

I. Bigalke ◽

K. Axcrona ◽

E. Inderberg ◽

G. Skorstad ◽

...

Keyword(s):

Prostate Cancer ◽

Dendritic Cell ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Radical Surgery ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

LPS-activated dendritic cell vaccine in combination with immunomodulatory dose of cytoxan in patients with stage IV melanoma: Phase I/IIa clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps313 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS313-TPS313 ◽

Author(s):

A. K. Palucka ◽

H. Ueno ◽

J. W. Fay ◽

J. Banchereau

Keyword(s):

Clinical Trial ◽

Dendritic Cell ◽

Phase I ◽

Stage Iv ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Stage Iv Melanoma

Download Full-text

Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy

Journal of Clinical Neuroscience ◽

10.1016/j.jocn.2007.08.007 ◽

2008 ◽

Vol 15 (2) ◽

pp. 114-121 ◽

Author(s):

David G. Walker ◽

Richard Laherty ◽

Frank H. Tomlinson ◽

Teong Chuah ◽

Chris Schmidt

Keyword(s):

Dendritic Cell ◽

Adjuvant Chemotherapy ◽

Phase I ◽

Vaccine Trial ◽

Dendritic Cell Vaccine ◽

Potential Interaction ◽

Cell Vaccine ◽

Malignant Astrocytoma

Download Full-text

Chemotherpay and Dendritic Cell Vaccine in Patient with Metastatic Melanoma: Phase II Prospective Randomized Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)33693-0 ◽

2012 ◽

Vol 23 ◽

pp. ix371

Author(s):

I.V. Samoylenko ◽

T.N. Zabotina ◽

I.N. Mikhaylova ◽

G.Z. Chkadua ◽

O.V. Korotkova ◽

...

Keyword(s):

Dendritic Cell ◽

Randomized Trial ◽

Metastatic Melanoma ◽

Phase Ii ◽

Dendritic Cell Vaccine ◽

Prospective Randomized Trial ◽

Download Full-text

Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2019.1680239 ◽

2019 ◽

Vol 16 (4) ◽

pp. 742-755

Author(s):

Robert O. Dillman ◽

Gabriel I. Nistor ◽

Aleksandra J. Poole

Keyword(s):

Dendritic Cell ◽

Complete Remission ◽

Metastatic Melanoma ◽

Dendritic Cell Vaccine ◽

Patient Specific ◽

Download Full-text

LPS activated dendritic cell vaccine in combination with immunomodulatory dose of cyclophosphamide in patients with stage IV melanoma: Preliminary report from the phase I/IIa clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.3049 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 3049-3049

Author(s):

A. K. Palucka ◽

E. Akagawa ◽

H. Ueno ◽

J. Fay ◽

J. Banchereau

Keyword(s):

Clinical Trial ◽

Dendritic Cell ◽

Phase I ◽

Preliminary Report ◽

Stage Iv ◽

Dendritic Cell Vaccine ◽

Cell Vaccine ◽

Stage Iv Melanoma

Download Full-text